Logo
x

Search

Subscribe Now

IASO Biotherapeutics

PharmaShots Weekly Snapshots (August 15 - 19, 2022)

PharmaShots Weekly Snapshots (August 15 - 19, 2022)

  • August 19, 2022
IASO Biotherapeutics' Equecabtagene Autoleucel Receives the NMPA’s IND Approval for Neuromyelitis Optica Spectrum Disorder

IASO Biotherapeutics' Equecabtagene Autoleucel Receives the NMPA’s IND Approval for Neuromyelitis Optica Spectrum Disorder

  • August 19, 2022
IASO Biotherapeutics Reports the NMPA’s Acceptance of IND Application for Equecabtagene Autoleucel to Treat Neuromyelitis Optica Spectrum Disorder

IASO Biotherapeutics Reports the NMPA’s Acceptance of IND Application for Equecabtagene Autoleucel to Treat Neuromyelitis Optica S...

  • May 30, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.